Bispecific CD20-directed CD3 T Cell Engager drugs
2 medications in the FDA established pharmacologic class “Bispecific CD20-directed CD3 T Cell Engager”.
2 medications in the FDA established pharmacologic class “Bispecific CD20-directed CD3 T Cell Engager”.